L’evoluzione della medicina di precisione e personalizzata in oncologia: il ruolo della ricerca clinica accademica
28.03.2025
28-29 marzo 2025
HOTEL NH BOLOGNA DE LA GARE
Bologna
Tumore della mammella ereditario: un modello in evoluzione
14.02.2025
II Edizione
14 Febbraio 2025
HOTEL NH BOLOGNA DE LA GARE
Bologna
Carcinoma mammario triplo negativo: stato dell’arte e prospettive future in un contesto multidisciplinare
24.01.2025
24 gennaio 2025
Hotel Real Fini Baia del Re
Via Vignolese 1684
41126 Modena
An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line
13.01.2025
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
13.01.2025
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109)
10.01.2025
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years’ Follow-Up
09.01.2025
Adjuvant Pertuzumab and Trastuzumab in EarlyHuman Epidermal Growth Factor Receptor 2-PositiveBreast Cancer in the APHINITY Trial: Third InterimOverall Survival Analysis With Efficacy Update
08.01.2025
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study
07.01.2025
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study
06.01.2025
